|
NUP153 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.596600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.598000E-01 |
| Normal-vs-Stage2 |
3.934300E-02 |
| Normal-vs-Stage3 |
4.797200E-04 |
| Normal-vs-Stage4 |
2.258500E-03 |
| Stage1-vs-Stage2 |
1.332810E-01 |
| Stage1-vs-Stage3 |
3.764700E-03 |
| Stage1-vs-Stage4 |
1.342390E-02 |
| Stage2-vs-Stage3 |
5.625000E-01 |
| Stage2-vs-Stage4 |
6.106000E-01 |
| Stage3-vs-Stage4 |
9.862200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.014110E-02 |
| Normal-vs-AfricanAmerican |
6.324800E-03 |
| Normal-vs-Asian |
9.973400E-01 |
| Caucasian-vs-AfricanAmerican |
2.322000E-01 |
| Caucasian-vs-Asian |
4.774400E-01 |
| AfricanAmerican-vs-Asian |
2.394800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.407200E-04 |
| Normal-vs-Female |
2.809200E-01 |
| Male-vs-Female |
1.365810E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.358190E-01 |
| Normal-vs-Age(41-60Yrs) |
8.404200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.857500E-03 |
| Normal-vs-Age(81-100Yrs) |
4.667500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.193200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.156400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.254800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.711750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.429390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.412800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.286450E-01 |
| Normal-vs-Grade 2 |
3.344400E-01 |
| Normal-vs-Grade 3 |
1.276370E-03 |
| Normal-vs-Grade 4 |
5.5952999999942E-05 |
| Grade 1-vs-Grade 2 |
1.025210E-01 |
| Grade 1-vs-Grade 3 |
7.655700E-03 |
| Grade 1-vs-Grade 4 |
1.658630E-03 |
| Grade 2-vs-Grade 3 |
7.683900E-03 |
| Grade 2-vs-Grade 4 |
2.033000E-04 |
| Grade 3-vs-Grade 4 |
5.454400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.035000E-01 |
| Normal-vs-ccB subtype |
1.203330E-04 |
| ccA subtype-vs-ccB subtype |
2.02960000028618E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.922400E-02 |
| Normal-vs-N1 |
3.514800E-01 |
| N0-vs-N1 |
7.243000E-01 |
|
|
